Relation Between Stage of Endogenous Fungal Endophthalmitis and Prognosis

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2005 Dec 7

PMID 16331481

Citations 20

Authors

Hiroshi Takebayashi

Atsushi Mizota

Minoru Tanaka

Affiliations

Soon will be listed here.

Abstract

Background: Although many studies have been published on the risk factors and therapies for endogenous fungal endophthalmitis (EFE), only a few have been published on the relationship between the stage of EFE at the initial examination and the prognosis. Thus, the purpose of this study was to determine the relation between the stage of EFE at the initial examination and the prognosis.

Methods: A total of 103 eyes of 58 patients (40 men, 18 women) with EFE, examined over a 20-year period (1984-2004), were studied. The severity of the EFE at the initial examination was classified into four stages. In addition, the type of fungus, general status, initial and final visual acuity, findings of the anterior and posterior segments, latent fungal infection, duration from initial symptoms to initial visit, history of intravenous hyperalimentation (IVH), results of the Candida Detection System, and beta-D-glucan levels were analyzed.

Results: More than 95% of the patients had some type of underlying disorder. Candida albicans was detected initially in the blood in 40 patients. The stage of the EFE advanced as the time from the initial symptoms to the beginning of therapy increased. The final visual acuity was significantly correlated with the stage of EFE at the initial examination. In 20 of 21 patients, blood beta-D-glucan was positive, and 42 patients (90%) were receiving IVH.

Conclusions: Because the stage of EFE advanced with the time between the initial symptoms and the beginning of therapy, and because of the high correlation between the stage of EFE and the final visual acuity, it is very important that treatment be begun as soon as possible. Thus, in patients with visual symptoms and susceptible to opportunistic infections, an early consultation with an ophthalmologist is highly recommended.

Citing Articles

Endogenous Fungal Endophthalmitis: Causative Organisms, Treatments, and Visual Outcomes.

Chen K, Sun M, Chen Y, Chen Y, Wang N, Liu L J Fungi (Basel). 2022; 8(6).

PMID: 35736124 PMC: 9225322. DOI: 10.3390/jof8060641.

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia.

Sakai D, Matsumiya W, Kusuhara S, Nakamura M J Ophthalmic Inflamm Infect. 2021; 11(1):17.

PMID: 34121142 PMC: 8200333. DOI: 10.1186/s12348-021-00248-0.

Posterior hypopyon in fungal endogenous endophthalmitis secondary to presumably contaminated dextrose infusion.

Karkhur S, Afridi R, Menia N, Gupta N, Nguyen Q, Dogra M Am J Ophthalmol Case Rep. 2020; 18:100681.

PMID: 32373756 PMC: 7191180. DOI: 10.1016/j.ajoc.2020.100681.

Optical coherence tomography features of retinal lesions in Chinese patients with endogenous Candida endophthalmitis.

Zhuang H, Ding X, Gao F, Zhang T, Ni Y, Chang Q BMC Ophthalmol. 2020; 20(1):52.

PMID: 32059661 PMC: 7020574. DOI: 10.1186/s12886-020-01337-9.

Prognostic factors associated with visual outcome of salvageable eyes with posttraumatic endophthalmitis.

Lu X, Xia H, Jin C, Chen W, Ng D, Yan H Sci Rep. 2019; 9(1):12678.

PMID: 31481709 PMC: 6722068. DOI: 10.1038/s41598-019-49117-w.

References

Barrie T . The place of elective vitrectomy in the management of patients with Candida endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 1987; 225(2):107-13. DOI: 10.1007/BF02160341. View

Schiedler V, Scott I, Flynn Jr H, Davis J, Benz M, Miller D . Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004; 137(4):725-31. DOI: 10.1016/j.ajo.2003.11.013. View

Edwards Jr J, Bodey G, Bowden R, Buchner T, De Pauw B, Filler S . International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis. 1997; 25(1):43-59. DOI: 10.1086/514504. View

Pfaller M, Houston A, Coffmann S . Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol. 1996; 34(1):58-61. PMC: 228730. DOI: 10.1128/jcm.34.1.58-61.1996. View

Urbak S, Degn T . Fluconazole in the treatment of candida albicans endophthalmitis. Acta Ophthalmol (Copenh). 1992; 70(4):528-9. DOI: 10.1111/j.1755-3768.1992.tb02126.x. View

Laatikainen L, Tuominen M, von Dickhoff K . Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy. Am J Ophthalmol. 1992; 113(2):205-7. DOI: 10.1016/s0002-9394(14)71537-5. View

Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H . Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995; 345(8941):17-20. DOI: 10.1016/s0140-6736(95)91152-9. View

Tanaka M, Kobayashi Y, Takebayashi H, Kiyokawa M, Qiu H . Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients. Retina. 2001; 21(3):203-9. DOI: 10.1097/00006982-200106000-00001. View

Parke 2nd D, Jones D, Gentry L . Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982; 89(7):789-96. DOI: 10.1016/s0161-6420(82)34722-3. View

10.

Donahue S, Greven C, Zuravleff J, Eller A, Nguyen M, Peacock Jr J . Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994; 101(7):1302-9. DOI: 10.1016/s0161-6420(94)31175-4. View

11.

Price M, Gentry L . Incidence and significance of candida antigen in low-risk and high-risk patient populations. Eur J Clin Microbiol. 1986; 5(4):416-9. DOI: 10.1007/BF02075697. View

12.

Voss A, le Noble J, Verduyn Lunel F, Foudraine N, Meis J . Candidemia in intensive care unit patients: risk factors for mortality. Infection. 1997; 25(1):8-11. DOI: 10.1007/BF02113499. View

13.

Pittet D, Monod M, Suter P, Frenk E, Auckenthaler R . Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994; 220(6):751-8. PMC: 1234477. DOI: 10.1097/00000658-199412000-00008. View

14.

Essman T, Flynn Jr H, Smiddy W, Brod R, Murray T, Davis J . Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1997; 28(3):185-94. View

15.

Brooks R . Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med. 1989; 149(10):2226-8. View

16.

Brod R, Flynn Jr H, CLARKSON J, Pflugfelder S, Culbertson W, Miller D . Endogenous Candida endophthalmitis. Management without intravenous amphotericin B. Ophthalmology. 1990; 97(5):666-72; disc: 672-4. DOI: 10.1016/s0161-6420(90)32547-2. View

17.

Schulman J, Peyman G . Intravitreal corticosteroids as an adjunct in the treatment of bacterial and fungal endophthalmitis. A review. Retina. 1992; 12(4):336-40. DOI: 10.1097/00006982-199212040-00007. View

18.

Fung J, Donta S, Tilton R . Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease. J Clin Microbiol. 1986; 24(4):542-7. PMC: 268967. DOI: 10.1128/jcm.24.4.542-547.1986. View